0
Systematic Review ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 1 ? Systematic review or meta-analysis. Synthesizes findings across many studies. Strongest evidence. Environmental Sources Human Health Effects Nanoplastics Policy & Risk Sign in to save

Micro- and nanoplastics in the cardiovascular system: current evidence, research gaps: a systematic review

MEDICAL SCIENCE PULSE 2025 Score: 58 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Joanna Wiewióra, Monika Domagała, Izabela Domańska, Aleksandra Sagan, Emilia Majewska, Weronika Duda, Małgorzata Piśkiewicz

Summary

This systematic review examined how microplastics and nanoplastics affect the heart and blood vessels. Studies in both animals and human tissue found that these particles can cause blood vessel inflammation, disrupt heart function, and were even linked to higher rates of heart attack and stroke in people with plastic particles in their arteries.

Background: Microplastics and nanoplastics (MP-NPs) are major environmental pollutants that have gained attention due to their widespread presence in water, air, soil, and food. Their entry into the human body through inhalation, oral ingestion, or skin contact raises concerns about potential health risks, particularly cardiovascular effects.Aim of the study: This systematic review aims to evaluate the impact of MP-NPs on the cardiovascular system and their associated health consequences.Material and methods: A systematic literature search was conducted in PubMed using the following keywords: "microplastics," "nanoplastics," "cardiovascular system," "cardiotoxicity," and "environmental pollution" in various combinations. Studies published between 2015 and 2025 were included, focusing on both animal and human data.Results: The review followed PRISMA guidelines, and 29 studies were included after applying predefined eligibility criteria. Most studies were conducted on animals, demonstrating that MP-NPs affect heart function through cellular and structural changes. In rat and mouse models, exposure to MP-NPs led to mitochondrial damage, myocardial fibrosis, increased pro-inflammatory markers, altered glucose and insulin levels, and weight gain. Human data remain limited; however, MP-NPs have been detected in atherosclerotic plaques, with emerging evidence suggesting their contribution to plaque formation and lipid metabolism alterations. These mechanisms may increase the risk of myocardial infarction and stroke.Conclusions: Current evidence suggests that exposure to micro- and nanoplastics (MP-NPs) may negatively affect the cardiovascular system, particularly in experimental models. Animal studies consistently indicate structural and functional myocardial changes, including fibrosis, mitochondrial damage, and metabolic disturbances. However, these findings cannot be directly extrapolated to humans. Human data remain scarce and mostly observational, showing the presence of MP-NPs in atherosclerotic plaques and thrombi, with correlations to adverse cardiovascular outcomes.Given the methodological heterogeneity and high risk of bias across available studies, the overall strength of evidence remains low. Therefore, MP-NPs should currently be regarded as a potential—but not yet proven—cardiovascular risk factor.

Sign in to start a discussion.

More Papers Like This

Systematic Review Tier 1

Impacts of micro- and nanoplastic exposure on the cardiovascular system: a systematic review focused on in vivo studies

This systematic review summarizes 38 animal studies on how micro- and nanoplastics affect the heart and blood vessels. The research found that these tiny plastic particles can deposit in cardiovascular tissue, trigger inflammation and oxidative stress, and cause structural damage, raising concerns about potential heart health risks from ongoing plastic exposure.

Article Tier 2

Microplastics, Nanoplastics and Heart Contamination: The Hidden Threat

This review examines growing evidence that micro- and nanoplastics can accumulate in human cardiovascular tissues, including blood, heart muscle, and arterial plaques. Researchers found that these particles may contribute to heart and blood vessel problems through inflammation, oxidative stress, blood clotting, and direct tissue injury. The study identifies plastic particles as a potential new environmental risk factor for cardiovascular health.

Article Tier 2

Micro-nanoplastic induced cardiovascular disease and dysfunction: a scoping review

Researchers reviewed evidence from animal and human studies on how micro- and nanoplastics (MNPs) affect the heart and blood vessels, finding that MNPs can damage the inner lining of blood vessels, promote plaque buildup, and interfere with blood clotting — all of which raise the risk of heart disease. The review calls for more research to understand how much MNP accumulation occurs in the human cardiovascular system and what it means for long-term cardiac health.

Systematic Review Tier 1

From pollution to palpitations: the heart’s silent battle with microplastics

This systematic review examined 72 studies on how microplastics and nanoplastics affect the heart and blood vessels. The research found that these particles can impair heart function, cause tissue scarring, and trigger inflammation through oxidative stress. Smaller particles under 100 nanometers are especially concerning because they can penetrate deeper into the body, raising questions about the cardiovascular risks of long-term plastic particle exposure.

Article Tier 2

Micro- and nanoplastics: A new cardiovascular risk factor?

This review examines the growing evidence that micro- and nanoplastics may pose risks to the heart and blood vessels. Studies in animals and cell cultures show that these tiny plastic particles can enter the bloodstream, trigger inflammation, promote blood clotting, and damage blood vessel walls. While human data is still limited, the review suggests that micro- and nanoplastic exposure should be considered a potential new risk factor for cardiovascular disease.

Share this paper